Lineage Cell Therapeutics (NYSEAM:LCTX) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsBrian Culley - CEOIoana Hone - Head of Investor RelationsJill Howe - CFOJoseph Pantginis - Managing Director of Equity ResearchMayank Mamtani - Senior Managing Director and Group Head of HealthcareConference Call ParticipantsAlbert Lowe - Senior Research AnalystJack Allen - Senior Research AnalystNone - AnalystOperatorWelcome to the Lineage Cell Therapeutics 3rd Quarter 2025 Conference Call. At this ...

Lineage Cell Therapeutics (NYSEAM:LCTX) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsBrian Culley - CEOIoana Hone - Head of Investor RelationsJill Howe - CFOJoseph Pantginis - Managing Director of Equity ResearchMayank Mamtani - Group Head of Healthcare Equity ResearchYanan Yang - Equity Research AssociateConference Call ParticipantsAlbert Low - Senior Research AnalystJack Allen - Senior Research AnalystOperatorWelcome to the Lineage Cell Therapeutics 3rd Quarter 2025 Conference Call ...

Lineage Cell Therapeutics (NYSEAM:LCTX) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Speaker7Welcome to the Lineage Cell Therapeutics 3rd quarter 2025 conference call. At this time, all participants are in a listen-only mode. An audio webcast of this call is available on the Investors section of Lineage website at www.lineagecell.com. This call is subject to copyright and is the property of Lineage. Any recordings, reproductions or transmissions of this call without the express written consent of Lineag ...